Investigating how a specific protein affects brain inflammation after traumatic injury
NOX2 drives microglia-dependent neurodegeneration after traumatic brain injury
['FUNDING_R01'] · UNIVERSITY OF MARYLAND BALTIMORE · NIH-10909886
This study is looking at how a protein called NOX2 affects the brain's immune response after a traumatic brain injury, with the hope of finding new ways to help people recover better from their injuries.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF MARYLAND BALTIMORE (nih funded) |
| Locations | 1 site (BALTIMORE, UNITED STATES) |
| Trial ID | NIH-10909886 on ClinicalTrials.gov |
What this research studies
This research focuses on understanding the role of a protein called NOX2 in the brain's immune response following traumatic brain injury (TBI). It aims to explore how chronic inflammation caused by activated brain cells, known as microglia, contributes to ongoing brain damage and cognitive decline. By using advanced techniques like single-cell RNA sequencing, the researchers will identify different types of microglia and how they can be influenced to promote healing. The ultimate goal is to find new treatment strategies that could help improve recovery for TBI patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals aged 21 and older who have experienced a traumatic brain injury.
Not a fit: Patients who have not experienced a traumatic brain injury or those with other unrelated neurological conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that reduce brain inflammation and improve cognitive recovery in patients who have suffered traumatic brain injuries.
How similar studies have performed: Previous studies have shown promising results in targeting microglial activation for neuroprotection, indicating that this approach has potential for success.
Where this research is happening
BALTIMORE, UNITED STATES
- UNIVERSITY OF MARYLAND BALTIMORE — BALTIMORE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: STOICA, BOGDAN ADRIAN — UNIVERSITY OF MARYLAND BALTIMORE
- Study coordinator: STOICA, BOGDAN ADRIAN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.